D61.811 Other drug-induced pancytopenia

Billable ICD-10-CM code, FY2026. Acts as a Major Complication or Comorbidity (MCC) as a secondary diagnosis.

Excludes2 (not included here)

• aplastic anemia due to drugs (D61.1)

Applies from D61 Other aplastic anemias and other bone marrow failure syndromes

Excludes2 (not included here)

• neutropenia (D70.-)

Applies from D61.81 Pancytopenia

Excludes1 (never code together)

• pancytopenia (due to) (with) aplastic anemia (D61.9)
• pancytopenia (due to) (with) bone marrow infiltration (D61.82)
• pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01)
• pancytopenia (due to) (with) hairy cell leukemia (C91.4-)
• pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-)
• pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82)
• pancytopenia (due to) (with) myeloproliferative disease (D47.1)

Excludes2 (not included here)

• pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)

Risk adjustment (HCC)

• CMS-HCC V22: HCC 47 — Disorders of Immunity
• ESRD V24: HCC 47

MS-DRG index

Defines the logic of DRG(s) 808-810 in MDC 16.

Approximate ICD-9-CM (GEMs)

• 284.12 Other drug-induced pancytopenia

Code annotations containing back-references to D61.811

Back-references to D61

• Code First: M90.5 Osteonecrosis in diseases classified elsewhere ("hemoglobinopathy (D50-D64)")
• Type 1 Excludes: R71 Abnormality of red blood cells ("anemias (D50-D64)")

Diagnosis Index entries for D61.811

• Pancytopenia (acquired) › drug-induced NEC

Nearby codes

• D61.2 Aplastic anemia due to other external agents
• D61.3 Idiopathic aplastic anemia
• D61.8 Other specified aplastic anemias and other bone marrow failure syndromes
• D61.81 Pancytopenia
• D61.810 Antineoplastic chemotherapy induced pancytopenia
• D61.811 Other drug-induced pancytopenia (this code)
• D61.818 Other pancytopenia
• D61.82 Myelophthisis
• D61.89 Other specified aplastic anemias and other bone marrow failure syndromes
• D61.9 Aplastic anemia, unspecified